Medical Device Network on MSN
Epicore and MECFA partner on wearable cystic fibrosis test
Clinical evaluation of Chloride Tracker will be conducted by Marmara University in Istanbul.
Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the ...
Clinical Trials Arena on MSN
SpliSense begins phase IIb SPL84 trial for cystic fibrosis
SpliSense anticipates top-line results in the second half of 2027.
Epicore Biosystems, a leader in wearable biosensor platforms for continuous, non-invasive health monitoring, today announced a ...
Airway stem cell transplantation achieves functional restoration and long-term engraftment in preclinical models, promising new opportunities for patients without gene-targeted options.
Cystic fibrosis is an incurable genetic disorder. Since 2020, there has been a treatment that addresses the underlying cause, known as triple therapy ...
Nonsense mutations are estimated to cause about 11 percent of inherited genetic disorders. Those disorders number in the ...
For example, cystic fibrosis (CF) is caused by nonsense mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Engineered suppressor transfer RNAs (sup-tRNAs) — native tRNAs ...
KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), ...
Company to share insights on the advancing clinical profile and commercial vision for 4D-150Renowned retinal experts Dr. Arshad M. Khanani, MD, ...
From bringing your ID to the dentist to getting renovation support and revoking offensive licence plates, here are the latest ...
ALPHA | Overview of Technology◾️What is SciTech at Arcturus Therapeutics HoldingsDelivering RNA into the body as a "blueprint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results